Skip to content

Terje Rolf Pedersen

Oslo University Hospital

1 paper in the Anchorcite directory, published in 2017, cited 6,357 times in total.

ORCID profile

Research topics

Frequent co-authors

Papers

  1. Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine · 2017 · 6,357 citations

    BACKGROUND: Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving…

Metadata from OpenAlex (CC0).